BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 23545911)

  • 1. Efficacy of extended-release 45 mg oral minocycline and extended-release 45 mg oral minocycline plus 15% azelaic acid in the treatment of acne rosacea.
    Jackson JM; Kircik LH; Lorenz DJ
    J Drugs Dermatol; 2013 Mar; 12(3):292-8. PubMed ID: 23545911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-World Efficacy of Azelaic Acid 15% Gel for the Reduction of Inflammatory Lesions of Rosacea.
    Wirth PJ; Henderson Berg MH; Sadick N
    Skin Therapy Lett; 2017 Nov; 22(6):5-7. PubMed ID: 29091380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of topical azelaic acid for common skin disorders other than inflammatory rosacea.
    Del Rosso JQ
    Cutis; 2006 Feb; 77(2 Suppl):22-4. PubMed ID: 16566285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azelaic acid foam 15% in the treatment of papulopustular rosacea: a randomized, double-blind, vehicle-controlled study.
    Draelos ZD; Elewski B; Staedtler G; Havlickova B
    Cutis; 2013 Dec; 92(6):306-17. PubMed ID: 24416747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azelaic acid gel 15% in the management of papulopustular rosacea: a status report on available efficacy data and clinical application.
    Del Rosso JQ; Bhatia N
    Cutis; 2011 Aug; 88(2):67-72. PubMed ID: 21916272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial.
    Elewski BE; Fleischer AB; Pariser DM
    Arch Dermatol; 2003 Nov; 139(11):1444-50. PubMed ID: 14623704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on the management of rosacea: a status report on the current role and new horizons with topical azelaic acid.
    Del Rosso JQ; Kircik LH
    J Drugs Dermatol; 2014 Dec; 13(12):s101-7. PubMed ID: 25607798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of combined azelaic acid cream plus oral minocycline with oral isotretinoin in severe acne.
    Gollnick HP; Graupe K; Zaumseil RP
    Eur J Dermatol; 2001; 11(6):538-44. PubMed ID: 11701404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of 15% azelaic acid gel and 0.75% metronidazole gel for the topical treatment of papulopustular rosacea.
    Czernielewski J; Liu Y
    Arch Dermatol; 2004 Oct; 140(10):1282-3; author reply 1283. PubMed ID: 15492198
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy and safety of once-daily metronidazole 1% gel compared with twice-daily azelaic acid 15% gel in the treatment of rosacea.
    Wolf JE; Kerrouche N; Arsonnaud S
    Cutis; 2006 Apr; 77(4 Suppl):3-11. PubMed ID: 16706244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter study of topical azelaic acid 15% gel in combination with oral doxycycline as initial therapy and azelaic acid 15% gel as maintenance monotherapy.
    Thiboutot DM; Fleischer AB; Del Rosso JQ; Rich P
    J Drugs Dermatol; 2009 Jul; 8(7):639-48. PubMed ID: 19588640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azelaic acid (15% gel) in the treatment of acne rosacea.
    Gupta AK; Gover MD
    Int J Dermatol; 2007 May; 46(5):533-8. PubMed ID: 17472690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current topical and systemic approaches to treatment of rosacea.
    Korting HC; Schöllmann C
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):876-82. PubMed ID: 19508315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal management of papulopustular rosacea: rationale for combination therapy.
    Bhatia ND; Del Rosso JQ
    J Drugs Dermatol; 2012 Jul; 11(7):838-44. PubMed ID: 22777226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and safety of doxycycline 40 mg (30-mg immediate-release and 10-mg delayed-release beads) once daily as add-on therapy to existing topical regimens for the treatment of papulopustular rosacea: results from a community-based trial.
    Del Rosso JQ
    Cutis; 2010 Nov; 86(5 Suppl):16-25. PubMed ID: 21229827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinical overview of azelaic acid.
    Elewski B; Thiboutot D
    Cutis; 2006 Feb; 77(2 Suppl):12-6. PubMed ID: 16566283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase 3 randomized, double-blind, vehicle-controlled trial of azelaic acid foam 15% in the treatment of papulopustular rosacea.
    Draelos ZD; Elewski BE; Harper JC; Sand M; Staedtler G; Nkulikiyinka R; Shakery K
    Cutis; 2015 Jul; 96(1):54-61. PubMed ID: 26244354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azelaic acid in the treatment of papulopustular rosacea: a systematic review of randomized controlled trials.
    Liu RH; Smith MK; Basta SA; Farmer ER
    Arch Dermatol; 2006 Aug; 142(8):1047-52. PubMed ID: 16924055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Review of the Current Modalities for the Treatment of Papulopustular Rosacea.
    McGregor SP; Alinia H; Snyder A; Tuchayi SM; Fleischer A; Feldman SR
    Dermatol Clin; 2018 Apr; 36(2):135-150. PubMed ID: 29499797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigator-reported efficacy of azelaic acid foam 15% in patients with papulopustular rosacea: secondary efficacy outcomes from a randomized, controlled, double-blind, phase 3 trial.
    Solomon JA; Tyring S; Staedtler G; Sand M; Nkulikiyinka R; Shakery K
    Cutis; 2016 Sep; 98(3):187-194. PubMed ID: 27814413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.